We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

53 hedge funds and large institutions have $20.5M invested in ENZON PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $21.1M → $20.5M (-$656K)

7% less funds holding

Funds holding: 57 → 53 (-4)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
16
Closed
7
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$392K
2
AWW
Alan W. Weber
+$217K
3
Deutsche Bank
Deutsche Bank
Germany
+$59.2K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$48.8K
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$33.3K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$343K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$180K
3
Two Sigma Investments
Two Sigma Investments
New York
-$130K
4
BIT
BlackRock Institutional Trust
California
-$97.6K
5
Goldman Sachs
Goldman Sachs
New York
-$61.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Icahn Carl
Florida
$6.26M – – –
BIT
2
BlackRock Institutional Trust
California
$3.11M -$97.6K -94,348 -3%
Renaissance Technologies
3
Renaissance Technologies
New York
$2.32M +$392K +379,223 +21%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.43M +$48.8K +47,156 +4%
BIP
5
Brandes Investment Partners
California
$1.1M +$4.29K +4,150 +0.4%
BA
6
BlackRock Advisors
Delaware
$841K – – –
CSC
7
Cove Street Capital
California
$755K – – –
UBS Group
8
UBS Group
Switzerland
$752K +$1.11K +1,070 +0.2%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$470K – – –
Jacobs Levy Equity Management
10
Jacobs Levy Equity Management
New Jersey
$333K +$21.8K +21,100 +7%
Connor, Clark & Lunn Investment Management (CC&L)
11
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$278K +$33.3K +32,200 +14%
NFA
12
Nationwide Fund Advisors
Ohio
$235K – – –
AWW
13
Alan W. Weber
$223K +$217K +210,111 New
SIM
14
Spark Investment Management
New York
$206K -$15K -14,500 -7%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$193K – – –
CL
16
CSS LLC
Illinois
$168K – – –
Goldman Sachs
17
Goldman Sachs
New York
$167K -$61.9K -59,838 -28%
Millennium Management
18
Millennium Management
New York
$147K -$43.9K -42,426 -23%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$145K +$13.3K +12,901 +11%
AG
20
Algert Global
California
$132K – – –
Arrowstreet Capital
21
Arrowstreet Capital
Massachusetts
$122K – – –
BIM
22
Bogle Investment Management
Massachusetts
$116K -$8.76K -8,468 -7%
Northern Trust
23
Northern Trust
Illinois
$116K -$4.08K -3,949 -3%
GC
24
Globeflex Capital
California
$106K -$113 -109 -0.1%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$101K -$355 -343 -0.4%
1
2 3

ENZN Hedge Fund Activity: Q1 2015 in Review

53 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q1 2015, worth a combined $20.5M — down 3.1% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ENZN and 3 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 11 added.

The largest buyer was Renaissance Technologies, adding an estimated $392K. The largest seller was Invesco, exiting entirely with an estimated $343K sold.

  • 53 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q1 2015, down from 57 in Q4 2014.
  • Funds reported $20.5M of ENZON PHARMACEUTICALS INC stock for Q1 2015, down 3.1% quarter-over-quarter.
  • 3 funds opened new ENZON PHARMACEUTICALS INC positions in Q1 2015 and 7 closed out, a net change of -4 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q1 2015 was Renaissance Technologies, an estimated $392K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q1 2015 was Invesco, an estimated $343K sold.

Based on aggregated 13F filings for Q1 2015.